VGLL4
Transcription cofactor vestigial-like protein 4
Also known as: KIAA0121, VGLL4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14135
- Gene
- VGLL4
- Ensembl
- ENSG00000144560
- Chromosome
- 3
- Canonical length
- 290 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
Predicted to enable transcription coactivator binding activity. Involved in negative regulation of Wnt signaling pathway; negative regulation of cell growth; and negative regulation of hippo signaling. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
290 residues, UniProt reviewed canonical sequence.
>Q14135|VGLL4
1 METPLDVLSR AASLVHADDE KREAALRGEP RIQTLPVASA LSSHRTGPPP ISPSKRKFSM
61 EPGDEDLDCD NDHVSKMSRI FNPHLNKTAN GDCRRDPRER SRSPIERAVA PTMSLHGSHL
121 YTSLPSLGLE QPLALTKNSL DASRPAGLSP TLTPGERQQN RPSVITCASA GARNCNLSHC
181 PIAHSGCAAP GPASYRRPPS AATTCDPVVE EHFRRSLGKN YKEPEPAPNS VSITGSVDDH
241 FAKALGDTWL QIKAAKDGAS SSPESASRRG QPASPSAHMV SHSHSPSVVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VGLL4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- ovary: 66 nTPM
- blood vessel: 64 nTPM
- choroid plexus: 46 nTPM
- cervix: 45 nTPM
- fallopian tube: 43 nTPM
- endometrium: 41 nTPM
Single-cell type
- choroid plexus epithelial cells: 719 nCPM
- podocytes: 370 nCPM
- respiratory ionocytes: 368 nCPM
- cone photoreceptor cells: 366 nCPM
- salivary ionocytes: 336 nCPM
- lacrimal acinar cells: 316 nCPM
Immune cell
- basophil: 20 nTPM
- gdT-cell: 10 nTPM
- non-classical monocyte: 9.3 nTPM
- memory CD8 T-cell: 9 nTPM
- naive CD8 T-cell: 8.6 nTPM
- MAIT T-cell: 7 nTPM
Brain region
- choroid plexus: 177 nTPM
- hippocampal formation: 96 nTPM
- cerebral cortex: 94 nTPM
- thalamus: 92 nTPM
- medulla oblongata: 92 nTPM
- white matter: 89 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cardiac muscle cell proliferation
- negative regulation of cell growth
- negative regulation of DNA-templated transcription
- negative regulation of hippo signaling
- negative regulation of Wnt signaling pathway
- positive regulation of protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TDU repeat
- Transcription cofactor vestigial-like protein 4
- Transcription cofactor vestigial-like protein 4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VGLL4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VGLL4 as an antibody target. Whether an autoantibody or antibody against VGLL4 could matter depends on whether native VGLL4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VGLL4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label VGLL4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...